DETRIMENTAL IMPACT OF TOXICITY ON QUALITY OF LIFE IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH LENVATINIBOR SORAFENIB

被引:1
|
作者
Hudgens, S. [1 ]
Misurski, D. [2 ]
Meier, G. [2 ]
机构
[1] Clin Outcomes Solut, Tucson, AZ USA
[2] Eisai Inc, Woodcliff Lake, NJ USA
关键词
D O I
10.1016/j.jval.2017.08.084
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN2
引用
收藏
页码:A411 / A412
页数:2
相关论文
共 50 条
  • [1] Impact of sorafenib on quality of life in hepatocellular carcinoma
    Abraham, A. M.
    Nair, B.
    Anand, A. S.
    Kuriakose, V. G.
    ANNALS OF ONCOLOGY, 2018, 29 : 30 - 30
  • [2] Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Biselli, Maurizio
    Reggidori, Nicola
    Iavarone, Massimo
    Renzulli, Matteo
    Lani, Lorenzo
    Granito, Alessandro
    Piscaglia, Fabio
    Lorenzini, Stefania
    Alimenti, Eleonora
    Vara, Giulio
    Caraceni, Paolo
    Sangiovanni, Angelo
    Marignani, Massimo
    Gigante, Elia
    Brandi, Nicolo
    Gramenzi, Annagiulia
    Trevisani, Franco
    CANCERS, 2024, 16 (06)
  • [3] Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib
    Chen, D.
    Zhao, P.
    Li, S. -Q.
    Xiao, W. -K.
    Yin, X. -Y.
    Peng, B. -G.
    Liang, L. -J.
    EJSO, 2013, 39 (09): : 974 - 980
  • [4] Impact of statin on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib or lenvatinib
    Cho, Hyo Jung
    Han, Ji Eun
    Cheong, Jae Youn
    Kim, Soon Sun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S572 - S572
  • [5] The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Branco, Fernanda
    Alencar, Regiane S. M.
    Volt, Fernanda
    Sartori, Giovana
    Dode, Andressa
    Kikuchi, Luciana
    Tani, Claudia M.
    Chagas, Aline L.
    Pfiffer, Tulio
    Hoff, Paulo
    Carrilho, Flair J.
    de Mattos, Angelo Alves
    ANNALS OF HEPATOLOGY, 2017, 16 (02) : 263 - 268
  • [6] The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
    Han, Ji Eun
    Kim, Jisu
    Cheong, Jae Youn
    Kim, Soon Sun
    Lim, Sun Gyo
    Yang, Min Jae
    Noh, Choong-Kyun
    Lee, Gil Ho
    Eun, Jung Woo
    Park, Bumhee
    Cho, Hyo Jung
    CANCERS, 2024, 16 (02)
  • [7] IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Reggidori, N.
    Lani, L.
    Renzulli, M.
    Gramenzi, A.
    Iannone, G.
    Granito, A.
    Piscaglia, F.
    Golfieri, R.
    Trevisani, F.
    Biselli, M.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S151 - S151
  • [8] Hepatocellular carcinoma treated with sorafenib
    Han, G.
    Zhao, Y.
    Qi, X.
    Fan, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) : 1347 - 1348
  • [9] Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Pomej, Katharina
    Scheiner, Bernhard
    Park, Dabin
    Bauer, David
    Balcar, Lorenz
    Meischl, Tobias
    Mandorfer, Mattias
    Reiberger, Thomas
    Muller, Christian
    Trauner, Michael
    Pinter, Matthias
    CANCERS, 2020, 12 (10) : 1 - 14
  • [10] Impact of Surgery on Quality of Life in Patients with Hepatocellular Carcinoma
    Yoshihiro Mise
    Shouichi Satou
    Takeaki Ishizawa
    Junichi Kaneko
    Taku Aoki
    Kiyoshi Hasegawa
    Yasuhiko Sugawara
    Masatoshi Makuuchi
    Norihiro Kokudo
    World Journal of Surgery, 2014, 38 : 958 - 967